A heparin bolus is a single, rapid intravenous injection of unfractionated heparin designed to achieve immediate anticoagulation. In most therapeutic settings, the dose is calculated by body weight, commonly around 80 units per kilogram, pushed through a vein over a few seconds to a minute, and then followed by a continuous drip to keep the blood thinned. The procedure sounds simple, but the details surrounding it vary considerably depending on why the patient needs anticoagulation, how much they weigh, and what kind of monitoring is available.
What Happens During the Injection
The bolus itself is drawn from a vial of liquid heparin and injected directly into a vein, usually through an existing intravenous line. A nurse or other clinician calculates the dose, draws it into a syringe, and pushes it over a short window. In emergency rooms and intensive care units, this typically takes well under a minute. The goal is to flood the bloodstream with enough heparin to inhibit clot formation right away, rather than waiting for a slow infusion to build up over hours.
Heparin works by amplifying the activity of a protein your body already makes called antithrombin. On its own, antithrombin gradually neutralizes clotting factors in the blood. When heparin binds to it, the process speeds up dramatically, shutting down the clotting cascade almost immediately after the bolus enters the bloodstream. That speed is the whole point: in situations like a pulmonary embolism or an evolving heart attack, the clinical team cannot afford to wait.
Weight-Based Dosing and the Standard Protocol
The standard therapeutic protocol for conditions like venous thromboembolism calls for a bolus of 80 units per kilogram of body weight, followed by a continuous infusion of 18 units per kilogram per hour.1Drug Information Group. What literature supports a maximum dose of unfractionated heparin in patients with obesity? For a person who weighs about 70 kilograms (roughly 154 pounds), that comes out to around 5,600 units pushed all at once, then about 1,260 units per hour dripping through the IV.
Not every clinical scenario uses the same numbers. In some hospital protocols for acute coronary syndromes, the bolus may be lower, around 60 units per kilogram. Cardiac catheterization labs use higher boluses, sometimes in the range of 70 to 100 units per kilogram, to prevent clotting on guidewires and catheters during procedures. The numbers shift because the acceptable level of bleeding risk changes depending on the situation. A patient getting a stent in a catheterization lab is under direct observation with a surgical team standing by, so the math tips in favor of heavier anticoagulation.
How Clinicians Monitor the Effect
After the bolus goes in, blood tests confirm whether the dose hit the target. The most common test is the activated partial thromboplastin time, or aPTT, which measures how long it takes a blood sample to clot in a test tube. Hospitals set a therapeutic range, typically about 1.5 to 2.5 times the patient’s baseline clotting time, and adjust the infusion rate up or down based on repeat aPTT checks drawn every six hours or so until the results stabilize.
A newer monitoring approach uses anti-factor Xa assays, which directly measure how much heparin activity is in the plasma. For children, guidelines from the American College of Chest Physicians recommend titrating heparin to an anti-Xa range of 0.35 to 0.7 units per milliliter.2PubMed Central. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Many adult hospitals are moving in the same direction, finding that anti-Xa levels give a more consistent picture of actual heparin effect than aPTT, which can be thrown off by other factors in the blood.
In cardiac surgery, the monitoring tool is the activated clotting time, or ACT, a bedside test that gives results in seconds rather than requiring a lab. The ACT is fast and practical in an operating room, but it has a known limitation: during cardiopulmonary bypass, it can overestimate heparin levels by a wide margin, with values reaching up to roughly three times what a more precise anti-Xa assay would show.3PubMed. Heparin monitoring during cardiac surgery. Part 2: Calculating the overestimation of heparin by the activated clotting time Surgical teams account for this by using ACT targets high enough that even an overestimation still keeps the patient safely anticoagulated.
Cardiac Surgery and High-Dose Boluses
Open-heart surgery represents the most extreme version of a heparin bolus. When a patient goes on a heart-lung machine, their blood circulates through plastic tubing and an oxygenator, all of which trigger clotting. To prevent that, surgeons give a much larger bolus, typically 300 units per kilogram or higher, sometimes reaching 600 units per kilogram. In a randomized study comparing these two dose levels in patients undergoing coronary artery bypass, the higher-dose group received roughly 45,000 units on average versus about 28,000 units in the lower-dose group. The higher dose led to less thrombin generation and less platelet activation during bypass.4PubMed. The effects of high-dose heparin on inflammatory and coagulation parameters following cardiopulmonary bypass
These surgical doses dwarf what you would see on a medical floor. The bolus is injected directly into a central venous line or sometimes into the heart itself, and the surgical perfusionist monitors the ACT continuously throughout the case, adding supplemental heparin doses if it drops below the target. At the end of surgery, protamine sulfate, a drug that binds and neutralizes heparin, reverses the anticoagulation before closing the chest.
Reversing the Bolus with Protamine
Protamine is essentially the antidote to heparin. It is a positively charged protein that binds to negatively charged heparin molecules, forming an inactive complex. The standard reversal ratio is about 1 milligram of protamine for every 100 units of heparin given, though some surgical teams use lower ratios. One study compared a group receiving 0.6 milligrams of protamine per 100 units of heparin against a group receiving 1.2 milligrams per 100 units.5Academic Journal of Health Sciences. Relationship between protamine dosage for reversing heparin effects in cardiopulmonary bypass surgery and hemostatic and metabolic outcomes
Protamine itself carries risks: it can cause a sudden drop in blood pressure, and in rare cases, severe allergic reactions. To manage this, many institutions administer a small test dose first, around 10 milligrams, watch for a reaction, and then give up to half the total dose before removing surgical cannulas, followed by the remainder afterward.6J Extra Corpor Technol. Protamine dose to neutralize heparin at the completion of cardiopulmonary bypass can be reduced significantly without affecting post-operative bleeding Heparin neutralization is then confirmed with a follow-up ACT. Outside of surgery, protamine reversal is less common. On a medical floor, the usual approach to stopping heparin’s effect is simply to turn off the infusion and wait, since the drug’s half-life is short, roughly 60 to 90 minutes.
The Dosing Challenge in Obesity
Weight-based dosing runs into a real problem when the patient is significantly overweight. If you multiply 80 units per kilogram by, say, 150 kilograms, you get 12,000 units in a single bolus, which raises concern about excessive anticoagulation and bleeding. The trouble is that heparin distributes primarily in the blood and in well-perfused tissues, not proportionally into body fat. Using total body weight can overshoot the actual drug need, but using ideal body weight can undershoot it.
One commonly suggested compromise is an adjusted body weight formula that takes ideal body weight and adds a fraction of the excess. Proposals include adding 30 to 40 percent of the difference between actual and ideal weight.7PubMed. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature In practice, though, the evidence is thin. A study comparing total body weight dosing to adjusted body weight dosing in an emergency department setting found no significant difference in the time it took patients to reach a therapeutic anti-Xa level, with both groups landing around 14 to 15 hours.8PubMed. Emergency Department Management of Acute Venous Thromboembolism in Patients With Obesity With Intravenous Unfractionated Heparin and Anti-Xa Monitoring Safety outcomes were also similar between groups.
A separate hospital pharmacy study found that among patients dosed by total body weight who received an initial bolus, only about a third achieved a therapeutic level on their first lab check, compared with half of those dosed by adjusted body weight, though the difference was not statistically significant given the small adjusted-weight group.9PubMed Central. Adjusted Versus Total Body Weight Dosing for Intravenous Heparin Infusions and Target Attainment in Obese Patients The honest summary is that neither approach has been clearly proven superior, and many hospitals set a maximum cap on the bolus, often around 10,000 units, regardless of calculated weight, to limit the risk of a dangerously supratherapeutic first dose.
Heparin Flushes Are Not Boluses
One common source of confusion, both for patients and sometimes for staff, is the difference between a heparin bolus and a heparin flush. A flush is a tiny amount of dilute heparin, typically 10 to 100 units, pushed through an IV catheter to keep it from clogging. The purpose is maintenance of the line, not anticoagulation of the patient. The volumes involved are so small that they have virtually no systemic effect on clotting.
A Cochrane review comparing heparin flushes to plain saline flushes for central venous catheters found that heparin locks modestly reduced catheter occlusion, with about a 30 percent relative reduction in blocked catheters compared with saline.10PubMed Central. Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults But there was no clear difference in catheter-related infection, mortality, or serious bleeding. The practical takeaway is that while some hospitals still use heparin flushes, others have switched entirely to saline flushes. Either way, the quantities bear no resemblance to a therapeutic bolus.
When the Standard Dose Does Not Work
Occasionally, a patient receives the expected bolus and infusion rate and still does not reach a therapeutic aPTT or anti-Xa level. This situation is known as heparin resistance. The most common cause is a deficiency of antithrombin, the very protein heparin needs to work. Without enough antithrombin circulating in the blood, even large doses of heparin cannot adequately suppress clotting.11PubMed Central. To be or not to be a case of heparin resistance
Antithrombin deficiency can be inherited or acquired. The congenital form is rare, affecting roughly 1 in 3,000 people, who typically have antithrombin levels between 40 and 60 percent of normal.12Journal of Extra Corporeal Technology. Heparin resistance management during cardiac surgery: a literature review and future directions Acquired deficiency is more common and can occur during prolonged heparin therapy itself, during major surgery, or in conditions like disseminated intravascular coagulation, where antithrombin gets consumed faster than the body can replace it.13PubMed. Heparin resistance and antithrombin deficiency The fix is often to infuse antithrombin concentrate directly, restoring the cofactor heparin needs to function, or to switch to a different anticoagulant like argatroban that works independently of antithrombin.
Heparin-Induced Thrombocytopenia
The most feared complication unique to heparin therapy is heparin-induced thrombocytopenia, or HIT. Paradoxically, this immune reaction to heparin does not just lower the platelet count; it actually triggers new blood clots. The mechanism involves antibodies that form against complexes of heparin and a platelet protein called platelet factor 4. These antibodies bind to platelets and activate them, creating a hypercoagulable state that can cause life-threatening clots in arteries or veins.14Blood. Heparin-induced thrombocytopenia
HIT typically develops five to ten days after heparin exposure, though it can occur faster in patients who have been exposed previously. Without early recognition, the mortality rate has been estimated at around 20 percent.15PubMed Central. Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management Clinicians monitor for it by watching the platelet count: a drop of 50 percent or more from baseline, especially during the typical time window, raises a red flag. If HIT is suspected, all heparin must be stopped immediately, including heparin flushes and heparin-coated catheters, and an alternative anticoagulant started. This is one of the few situations where the distinction between a heparin flush and a therapeutic bolus becomes life-or-death: even the small amount in a catheter flush can trigger HIT in a sensitized patient.
Heparin During Pregnancy
Unfractionated heparin does not cross the placenta, which makes it one of the safer anticoagulant options during pregnancy. When a pregnant patient develops a blood clot, treatment may begin with an intravenous bolus followed by a continuous infusion, maintained with aPTT monitoring, for at least five days. After the acute phase, the patient can transition to subcutaneous heparin injections for the remainder of the pregnancy.16ScienceDirect (Journal of Thrombosis and Haemostasis). Management of venous thromboembolism during pregnancy The subcutaneous approach uses adjusted doses given two or three times daily, with periodic aPTT checks to maintain therapeutic levels.
Low-molecular-weight heparins have largely replaced unfractionated heparin in pregnancy for routine clot prevention, since they need less monitoring and are easier to administer at home. But unfractionated heparin retains a role around the time of delivery because its short half-life and reversibility with protamine give the obstetric team more control. Switching from a longer-acting heparin to intravenous unfractionated heparin in the final weeks allows the team to stop the drip when labor begins and restart it afterward.
Heparin in Dialysis
Hemodialysis sends blood through an external circuit, much like cardiac bypass but at lower pressures. Without anticoagulation, the dialysis filter and tubing would clot within minutes. The standard approach is a heparin bolus at the start of the session, often followed by smaller intermittent doses or a low-rate infusion to maintain anticoagulation throughout the three- to four-hour treatment. Dosage schedules vary and include weight-based protocols as well as low-dose approaches for patients at higher bleeding risk.17PubMed Central. Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysis
Some dialysis patients receive heparin three times a week for years. This prolonged, repeated exposure is one reason dialysis patients are monitored for HIT, though the risk per session is low. For patients who have already developed HIT or who are at very high bleeding risk, alternatives include saline flushes alone, regional citrate anticoagulation, or heparin-coated dialyzers that reduce the need for systemic dosing.
Preventing Errors at the Bedside
Heparin is consistently ranked among the highest-risk medications in hospitals. Dosing errors with heparin can be catastrophic: too much causes uncontrollable bleeding, too little leaves the patient vulnerable to clot progression. Several features of heparin make it uniquely error-prone. It comes in multiple concentrations, the dose is weight-dependent, and it requires ongoing lab monitoring with frequent rate adjustments.
One quality-improvement initiative tackled the concentration problem head-on by removing high-concentration heparin vials (25,000 units in 5 milliliters) from an entire hospital, leaving only 1,000-unit-per-milliliter vials available in all patient-care areas.18PubMed Central. Improving the safety of heparin usage by standardisation of practice The rationale was straightforward: when staff only handle one concentration, the math is simpler and the chance of a tenfold dosing error drops sharply. Other safeguards commonly used alongside standardization include computerized weight-based dosing calculators, double-checks by a second nurse before administration, barcode scanning at the bedside, and standardized nomograms that map aPTT results to specific infusion-rate changes.
Pediatric patients face an even higher risk of calculation error, since the doses are much smaller and the margin for mistakes is tighter. The American College of Chest Physicians recommends titrating pediatric heparin to anti-Xa levels rather than relying on aPTT, in part because the anti-Xa assay is less susceptible to the developmental differences in clotting factors seen in young children.2PubMed Central. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Premixed heparin bags with pre-calculated concentrations for neonatal use have become standard in many pediatric units for the same reason: removing the math removes the error.
Why Hospitals Still Use Unfractionated Heparin
Given the monitoring burden and the error risk, it is reasonable to wonder why hospitals have not abandoned unfractionated heparin entirely in favor of newer anticoagulants. The answer comes down to three practical advantages that no substitute fully matches. First, its half-life is short, so the anticoagulant effect fades quickly once the drip is stopped, which matters when a patient might need emergency surgery. Second, it can be reversed instantly with protamine, which is critical in cardiac surgery and trauma settings. Third, it can be monitored in real time at the bedside with an ACT, allowing minute-to-minute dose adjustments during complex procedures.
Low-molecular-weight heparins, direct oral anticoagulants, and direct thrombin inhibitors have each chipped away at unfractionated heparin’s dominance in specific clinical niches. But in acute care settings where rapid onset, rapid offset, and reliable reversal all matter at once, unfractionated heparin delivered as a bolus followed by a drip remains the standard. The drug discovered in 1916 and first used clinically in the 1930s still occupies a central place in modern hospital medicine.19PubMed. History of heparin